Variables | Responses | Male (N = 334) % (95% CI) | Female (N = 357) % (95% CI) | Total (N = 691) % (95% CI) |
---|---|---|---|---|
What is filariasis? | Elephantiasis | 61.6(65.4–74.8) | 70.3(65.4–74.8) | 67.8(64.3–71.3) |
Lymphedema and elephantiasis | 32.5(27.7–37.5) | 29.1(24.6–34.0) | 31.7(28.3–35.2) | |
Do not know | 0.3(0.01–1.4) | 0.56(0.1–1.70) | 0.43(0.11–1.17) | |
Mode of transmission for filariasis? | Mosquito bite | 90.4(86.9–93.2) | 85.4(81.5–88.8) | 87.8(85.2–90.1) |
Hereditary/contagious | 8.7(6.0–12.0) | 13.1(9.9–16.5) | 11(8.8–13.5) | |
Do not know | 0.9(0.22–2.42) | 1.4(0.5–3.07) | 1.15(0.54–2.2) | |
Most common symptoms | Swelling of limbs | 60.4(55.2–65.7) | 34.0(29.1–39.0) | 46.7(43.0–50.5) |
Fever and swelling | 38.6(33.5–44.0) | 65.2(60.2–70.0) | 52.4(48.6–56.1) | |
Do not know | 0.9(0.22–2.42) | 1.12(0.35–2.68) | 1.0(0.44–2.0) | |
Treatment | Medicine | 90.1(86.5–93.0) | 85.0(80.5–88.0) | 87.3(84.6–89.6) |
Not curable | 8.9(6.25–12.42) | 13.4(10.2–17.3) | 11.3(9.1–13.8) | |
Do not know | 0.9(0.22–2.42) | 1.96(0.9–3.8) | 1.4(0.7–2.56) | |
Knowledge regarding the distribution of filarial tablets for prevention | Yes | 95.5(92.9–97.4) | 90.5(87.0–93.2) | 92.9(90.8–94.6) |
No | 4.5(2.63–7.13) | 9.5(6.8–12.9) | 7.1(5.35–9.20) | |
Do you consider yourself to be at risk? | Yes | 86.5(82.5–89.9) | 80.9(76.6–84.7) | 83.6(80.7–86.3) |
No | 12.3(9.0–16.13) | 17.08(13.4–21.2) | 14.7(12.2–17.5) | |
Do not know | 1.2(0.4–2.9) | 1.96(0.9–3.8) | 1.6(0.83–2.75) |